Black Diamond Therapeutics, Inc.
BDTX
$2.02
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.62% | 40.22% | -77.88% | 19.53% | -118.68% |
| Total Depreciation and Amortization | 3.70% | -59.09% | -23.26% | 0.00% | -1.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.28% | -80.21% | 313.54% | 5.47% | 3.92% |
| Change in Net Operating Assets | 100.59% | -209.11% | 41.01% | -108.07% | 84.70% |
| Cash from Operations | 22.13% | -50.76% | 13.54% | 14.29% | -117.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 200.00% | -90.00% | -23.08% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -116.02% | 774.27% | -133.67% | 114.52% | -793.26% |
| Cash from Investing | -116.02% | 774.97% | -133.63% | 114.52% | -792.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 5.61% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 217.30% | 5.61% | -246.27% | 215.52% | -462.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -219.73% | 192.01% | -1,229.52% | 101.28% | -210.39% |